Hematology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hematology stocks.

Hematology Stocks Recent News

Date Stock Title
Jul 5 ABT DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Jul 5 JNJ What's Going On With Johnson and Johnson Shares Friday?
Jul 5 JNJ J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?
Jul 5 IDXX IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 11% CAGR delivered to shareholders
Jul 4 ABT Is Abbott Laboratories (ABT) a Good Dividend Growth Stock to Buy and Hold According to Hedge Funds?
Jul 4 JNJ 3 High-Yield Dividend Stocks/ETFs to Buy Hand Over Fist in July
Jul 3 JNJ Johnson & Johnson receives Canadian approval for Rybrevant in first-line NSCLC
Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
Jul 3 JNJ Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
Jul 3 JNJ How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Jul 3 JNJ Health Canada Authorizes RYBREVANT® (amivantamab) in Combination with Carboplatin and Pemetrexed as the Only Targeted First-line Treatment Approved for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jul 3 JNJ Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
Jul 3 JNJ Johnson & Johnson gains FDA and EC approvals for TB treatment
Jul 3 JNJ Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
Jul 2 CERS Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
Jul 2 JNJ Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Jul 2 JNJ Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case
Jul 2 JNJ J&J says Carvykti beat standard drugs in late-stage blood cancer trial
Jul 2 JNJ CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study
Jul 1 JNJ 5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Hematology

Hematology, also spelled haematology, is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, blood clots, other bleeding disorders and blood cancers such as leukemia, multiple myeloma, and lymphoma. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Many hematologists work as hematologist-oncologists, also providing medical treatment for all types of cancer. The term is from the Greek αἷμα, haima meaning "blood," and -λoγία meaning study.

Browse All Tags